Association between sodium-glucose cotransporter 2 inhibitors and eye disorders: a systematic review and meta-analysis.
鈉-葡萄糖共轉運蛋白 2 抑制劑與眼部疾病之間的關聯:系統性回顧與統合分析。
Expert Rev Clin Pharmacol 2024-08-29
Comparative Cardiovascular Effectiveness of Empagliflozin Versus Dapagliflozin in Adults With Treated Type 2 Diabetes: A Target Trial Emulation.
經治療的2型糖尿病成人中,Empagliflozin與Dapagliflozin的心血管效果比較:一項目標試驗模擬。
Circulation 2024-08-29
Effects of Sodium-Glucose Cotransporter 2 Inhibitors in Diabetic and Non-Diabetic Patients with Advanced Chronic Kidney Disease in Peritoneal Dialysis on Residual Kidney Function: In Real-World Data.
鈉-葡萄糖共轉運蛋白 2 抑制劑在接受腹膜透析的糖尿病及非糖尿病晚期慢性腎病患者中對殘餘腎功能的影響:來自真實世界數據的研究。
Medicina (Kaunas) 2024-08-30
Effects of SGLT2-Inhibitors on Comprehensive Geriatric Assessment, Biomarkers of Oxidative Stress, and Platelet Activation in Elderly Diabetic Patients with Heart Failure with Preserved Ejection Fraction.
SGLT2 抑制劑對心臟功能保留的老年糖尿病患者的綜合老年評估、氧化壓力生物標記及血小板活化的影響。
Int J Mol Sci 2024-08-29
Retrospective Longitudinal Observational Study on the Long-Term Effects of Sodium-Glucose Cotransporter-2 Inhibitors on the Development of Metabolic Dysfunction-Associated Steatotic Liver Disease in Type 2 Diabetic Japanese Patients.
對於日本2型糖尿病患者,鈉-葡萄糖共轉運蛋白-2抑制劑對代謝功能障礙相關脂肪肝疾病發展的長期影響之回顧性縱向觀察研究。
J Clin Med 2024-08-29
Systematic Review of Left Ventricular Remodeling in Response to Hypoglycemic Medications: Assessing Changes in End-Systolic and End-Diastolic Diameters.
低血糖藥物對左心室重塑的系統性回顧:評估心臟收縮末期和舒張末期直徑的變化。
Biomedicines 2024-08-29